The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.
Subscribe to H|T using the form at the bottom of this page to ensure you don’t miss out on the most important healthtech news every week!
The insurance giant began piloting the service last year in Quebec and Ontario. With this expansion, Dialogue’s service will be rolled out to 10,000 employees across the country.
The round is led by FitLab, Causeway Media Partners, and Jazz Venture Partners, with participation from Courtside Ventures, Elysian Park Ventures, Ward Ventures, and business mogul Tony Robbins.
This round comes a couple of years after the Finnish company raised €5 million from MIT Media Lab Director Joi Ito and others.
Google’s DeepMind predicts 3D shapes of proteins (THEGUARDIAN)
Google’s DeepMind outfit has turned its artificial intelligence on one of the toughest problems in science.
Apple scoops up CEO of Mango Health, a startup that helps people keep track of their medications (CNBC)
One of the people familiar with his move said that Oberfest will look into opportunities for Apple in the medication adherence space, meaning helping people take their medicines on time.
A tiny startup wants to pay you for your DNA, and it could lead to the next wave of medical innovation (BUSINESSINSIDER)
A startup called LunaDNA is taking a new approach to genetic research by paying individuals to share their information with scientists.
Through their partnership, MyMeds users will be able to access medication-related educational content from Mayo Clinic.
BIOS raises $4.5M to further develop its ‘neural interface’ and new ways to treat chronic medical conditions (TECHCRUNCH)
The company is developing a “neural interface” that combines advances in hardware, big data and machine learning/AI, which it’s hoped can be used to develop new cutting-edge treatments on organs and nerve systems throughout the body.
TILT acquires cannabis distribution startup Blackbird and medical cannabis operator Standard Farms (FINANCIALPOST)
This announcement is the latest in a series of moves to expand TILT’s offerings for cannabis businesses and consumers.
The stock closed down 19.% to $18.60 in its trading debut on Friday, after pricing at $23 late on Thursday night.
3iOntario Digest presents a list of ongoing funding opportunities and other resources to accelerate health innovation.
CAN – Parkinson (read more)
CAN – Canadian Cancer Society (read more)
CAN – Canadian National Transplant Research Program (read more)